Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 1

1(20.0%)

Phase 3

1(20.0%)

Phase 4

1(20.0%)

5Total

N/A(2)

Phase 1(1)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05439135Not ApplicableRecruiting

Washed Microbiota Transplantation for Malnutrition After Nonphysiological Reconstruction of the Upper Gastrointestinal Tract

Role: collaborator

NCT07003191Active Not Recruiting

Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes

Role: collaborator

NCT05179733Phase 3Unknown

The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years

Role: collaborator

NCT05454397Unknown

A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients

Role: collaborator

NCT04988425Phase 1Unknown

TNFα Monoclonal Antibody for Acute Spinal Cord Injury

Role: collaborator

NCT02430207Not ApplicableUnknown

Incidence of Pulmonary Embolism During Temporary Pacing Via Femoral Versus Subclavian Vein

Role: collaborator

NCT01637844Phase 4Completed

Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBV

Role: collaborator

All 7 trials loaded